Stanker James H 4
4 · Processa Pharmaceuticals, Inc. · Filed Oct 3, 2022
Insider Transaction Report
Form 4
Stanker James H
Chief Financial Officer
Transactions
- Award
Restricted Stock Units
2022-06-30−23,947→ 326,713 totalExercise: $0.00→ Common Stock (23,947 underlying)
Footnotes (1)
- [F1]Each Restricted Stock Unit represents a contingent right to receive one share of the Issuer's common stock upon the earliest of: termination of employment; the third anniversary of the award date; a change of control; or the reporting person's death.